Jeff Himawan - Net Worth and Insider Trading

Jeff Himawan Net Worth

The estimated net worth of Jeff Himawan is at least $0 dollars as of 2024-11-13. Jeff Himawan is the Director of Horizon Therapeutics PLC and owns about 0 shares of Horizon Therapeutics PLC (HZNP) stock worth over $0. Details can be seen in Jeff Himawan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jeff Himawan has not made any transactions after 2015-03-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Jeff Himawan

To

Jeff Himawan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jeff Himawan owns 3 companies in total, including Horizon Therapeutics PLC (HZNP) , Catalyst Biosciences Inc (CBIO) , and MediciNova Inc (MNOV) .

Click here to see the complete history of Jeff Himawan’s form 4 insider trades.

Insider Ownership Summary of Jeff Himawan

Ticker Comapny Transaction Date Type of Owner
HZNP Horizon Therapeutics PLC 2015-03-13 director & 10 percent owner
CBIO Catalyst Biosciences Inc 2015-08-20 director
MNOV MediciNova Inc 2006-01-09 director

Jeff Himawan Latest Holdings Summary

Jeff Himawan currently owns a total of 1 stock. Jeff Himawan owns 0 shares of Horizon Therapeutics PLC (HZNP) as of March 13, 2015, with a value of $0.

Latest Holdings of Jeff Himawan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HZNP Horizon Therapeutics PLC 2015-03-13 0 116.30 0

Holding Weightings of Jeff Himawan


Jeff Himawan Form 4 Trading Tracker

According to the SEC Form 4 filings, Jeff Himawan has made a total of 0 transactions in Horizon Therapeutics PLC (HZNP) over the past 5 years. The most-recent trade in Horizon Therapeutics PLC is the sale of 554,564 shares on March 13, 2015, which brought Jeff Himawan around $12 Million.

Insider Trading History of Jeff Himawan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jeff Himawan Trading Performance

GuruFocus tracks the stock performance after each of Jeff Himawan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jeff Himawan is 3.28%. GuruFocus also compares Jeff Himawan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jeff Himawan within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jeff Himawan's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jeff Himawan

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 5.31 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 6.7 LIMIT LIMIT LIMIT LIMIT LIMIT

Jeff Himawan Ownership Network

Ownership Network List of Jeff Himawan

No Data

Ownership Network Relation of Jeff Himawan

Insider Network Chart

Jeff Himawan Owned Company Details

What does Horizon Therapeutics PLC do?

Who are the key executives at Horizon Therapeutics PLC?

Jeff Himawan is the director & 10 percent owner of Horizon Therapeutics PLC. Other key executives at Horizon Therapeutics PLC include EVP and Chief Business Officer Andy Pasternak , EVP & Chief Financial Officer Aaron Cox , and EVP & Chief Medical Officer Jeffrey W Sherman .

Horizon Therapeutics PLC (HZNP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Horizon Therapeutics PLC (HZNP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Horizon Therapeutics PLC (HZNP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Horizon Therapeutics PLC (HZNP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Horizon Therapeutics PLC Insider Transactions

No Available Data

Jeff Himawan Mailing Address

Above is the net worth, insider trading, and ownership report for Jeff Himawan. You might contact Jeff Himawan via mailing address: Essex Woodlands Health Ventures, 435 Tasso Street, Suite 350, Palo Alto Ca 94301.